The Framingham Study established hypertension as a major cardiovascular ris
k factor and quantified its atherogenic cardiovascular disease potential. A
n historical perspective is presented on the epidemiological insights about
hypertension derived from 50 years of Framingham Study research into the p
revalence, incidence, determinants and hazards of hypertension. Existing mi
sconceptions about the presence of critical levels of blood pressure, the i
mpact of the systolic and diastolic components of blood pressure, the hazar
d 'mild' hypertension, the impact in advanced age and the hazard of left ve
ntricular hypertrophy. The importance of isolated systolic hypertension and
the pulse pressure were demonstrated. It has been demonstrated that hypert
ension seldom occurs in isolation of other atherogenic risk factors, with w
hich it tends to cluster. This clustering with other metabolically linked r
isk factors has been shown to reflect insulin resistance promoted by weight
gain and abdominal obesity. Obesity was shown to be one of the major deter
minants of hypertension in the general population. Left ventricular hypertr
ophy was shown to be an ominous harbinger of cardiovascular disease rather
than an incidental compensatory phenomenon. Multivariate risk profiles for
coronary disease, stroke, peripheral artery disease and heart failure have
been devised to facilitate incorporation of elevated blood pressure in a gl
obal, multivariate cardiovascular risk assessment.